Kestra Medical Technologies (KMTS) Capital Expenditures (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Capital Expenditures data on file, last reported at -$24.8 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 7092.17% year-over-year to -$24.8 million in Q2 2026; TTM through Apr 2026 was $415000.0, a 77.87% decrease from a year earlier, with the FY2026 full-year figure at $415000.0, down 77.87% from the prior year.
• Capital Expenditures for Q2 2026 stood at -$24.8 million, down from $9.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for KMTS reached as high as $15.4 million in Q4 2025 and fell as low as -$24.8 million in Q2 2026.
• Historically, Capital Expenditures has averaged -$646333.3 across 3 years, with a median of -$10000.0 in 2024.
• On a YoY basis, Capital Expenditures climbed as much as 205.75% in 2026 and fell as far as 7092.17% in 2026.
• Year by year, Capital Expenditures stood at $11.5 million in 2024, then jumped by 34.34% to $15.4 million in 2025, then plunged by 260.7% to -$24.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$24.8 million in Q2 2026, $9.8 million in Q1 2026, and $15.4 million in Q4 2025.